18 July, 2010
GlaxoSmithKline has agreed to Avandia lawsuit settlements totaling about $460 million
Our experienced Avandia lawsuit attorneys are accepting cases in all 50 states. If you or a loved has suffered an Avandia heart attack, stroke, heart failure or Avandia heart-related death, call us toll free at 800-845-6913 or fill out our short online contact form and an Avandia lawsuit attorney will contact you for a free no-obligation consultation. Let us answer all of your questions and help you recover the compensation you deserve. Continue reading Avandia Lawsuit Settlements
Category: Avandia Lawsuit | Avandia Settlements | Avandia Side Effects16 July, 2010
Avandia lawsuits have been filed by diabetics and their families against drug manufacturer GlaxoSmithKline to collect financial compensation for personal injury and wrongful death damages.
Avandia lawsuit attorneys claim GSK intentionally misled doctors and the public about the drug’s safety and efficacy. Lawyers also claim Glaxo was negligent. Please contact us for the latest Avandia lawsuit 2010 news. Continue reading Avandia Lawsuit 2010 Information
Category: Avandia Lawsuit | Avandia News1 June, 2010
The Avandia lawsuit scheduled for the first trial has been settled.
GSK has reached Avandia lawsuit settlements in more cases, but the number of cases settled and the settlement amounts remains confidential. Continue reading Settlement reached as first Avandia trial to begin
Category: Avandia Lawsuit | Avandia Settlements29 May, 2010
The trial Saudi FDA recall of Avandia is questioned while Avandia lawsuit settlements are reached in the U.S..
Despite growing evidence of the cardiovascular risks associated with Avandia, a leading Saudi diabetes doctor would like to its FDA recall reversed. Meanwhile, the first round Avandia lawsuit settlements have been reported in the U.S.. Continue reading Saudi FDA recall of Avandia is questioned while Avandia lawsuit settlements are reached in U.S.
Category: Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Settlements16 May, 2010
GlaxoSmithKline may pay more than $1 billion to settle Avandia lawsuits.
The defective drug litigation has reached the point where more Avandia settlements are expected in the near future. Continue reading Avandia settlements may exceed $1 billion
28 April, 2010
GlaxoSmithKline Q1 profits beat analysts’ estimates as progress is made toward settlement of Avandia lawsuits.
Without specifically mentioning Avandia, the diabetes drug manufacturer stated that legal costs for the quarter increased by over $319 million due to “the progress we are making towards settlement of a number of existing cases.” Over 2,000 Avandia lawsuits have been filed against Glaxo following a 2007 New England Journal of Medicine article linking Avandia to an increased risk of heart attack. Continue reading Progress made toward Avandia lawsuit settlements, Glaxo Q1 profit over $2 billion
Category: Avandia Lawsuit | Avandia News | Avandia Settlements11 March, 2010
Avandia heart side effects lawsuits could cost GlaxoSmithKline up to $6 billion, said UBS analysts in a note made public last week.
The UBS note follows a highly critical report on the drug by the U.S. Senate Finance Committee. Over 13,000 Avandia personal injury and wrongful death lawsuits currently are pending against the GSK… Continue reading Avandia side effects lawsuit settlements could top $6 billion in liability for GSK
Category: Avandia Lawsuit | Avandia News | Avandia Senate Report | Avandia Settlements | Avandia Side Effects | Avandia Warning23 February, 2010
The U.S. Food and Drug Administration is reviewing data on possible heart risks with GlaxoSmithKline diabetes drug Avandia but has not reached any new conclusions. The FDA will hold a public meeting in July 2010 to discuss the risks and benefits of the Avandia, but said in the meantime doctors and patients should continue to use Avandia Continue reading FDA: No new conclusions on Glaxo's Avandia yet
Category: Avandia Cardiovascular Risk | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Safety